De Leon
FDA investigator
Appears on 2 documents from 2016, mostly at sites in Washington. Most often cites control of microbiological contamination (21 CFR 211.113).
- 2
- Documents on file
- 7.5
- Observations per 483
- 2016
- First seen
- 2016
- Most recent
What they cite most
From 15 observations- 21 CFR 211.113Control of microbiological contamination4
- 21 CFR 211.42Design and construction features4
- 21 CFR 211.167Special testing requirements2
- 21 CFR 211.28Personnel responsibilities2
- 21 CFR 211.137Expiration dating1
- 21 CFR 211.166Stability testing1
Activity by year
2016: 2
Where
Washington 2
Often inspects with
Is De Leon coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
2 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2016-08-04 | 483 University of Washington Medical Center Inpatient PharmacyAug 4, 2016 · Seattle, Washington | Seattle, Washington | 8 | |
| 2016-05-17 | 483 Ballard Plaza Pharmacy 1 Inc.May 17, 2016 · Seattle, Washington | Seattle, Washington | 7 |
About this profile
What does De Leon inspect?
De Leon appears on 2 documents on file covering 2 sites, mostly in Washington.
What do they cite most often?
21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.42 and 21 CFR 211.167.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for De Leon is dated Aug 4, 2016.